சந்தித்தல் ஆஃப் தி உயிர் இயற்பியல் சமூகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Nanobowls are a Potential Way to Deliver Treatments for Alzheimer s Disease

Nanobowls are a Potential Way to Deliver Treatments for Alzheimer’s Disease Written by AZoNanoMar 1 2021 Researchers still have a long path to tread before they can treat Alzheimer’s Disease, partially because the protein aggregates that can turn into brain plaques, a characteristic attribute of the disease, are challenging to analyze. The amyloid beta protein that tangles to form the hallmark Alzheimer’s brain plaques, cling to ultra-small “bowls,” called nanobowls, scientists find. They can use these nanobowls to remove the toxic amyloid aggregates and further study them. Image Credit: Vrinda Sant. The plaques are formed due to the amyloid beta protein, the shape of which gets altered and tangled in the brain. The investigation of these protein aggregates in tissue samples often requires techniques that can disrupt them further, which makes it hard to figure out what occurs there.

United statesSan diegoRatnesh lalVrinda santUniversity of californiaMeeting of the biophysical societyMadhura somAnnual meetingGraduate studentஒன்றுபட்டது மாநிலங்களில்சான் டியாகோறத்னேஷ் லால்விரிந்த சந்த்பல்கலைக்கழகம் ஆஃப் கலிஃபோர்னியாசந்தித்தல் ஆஃப் தி உயிர் இயற்பியல் சமூகம்மதுரா சோம்

Nanotechnology Now - Press Release: Nanoparticles help untangle Alzheimer s disease amyloid beta plaques: New research shows that the protein that causes Alzheimer s disease s hallmark brain plaques clings to certain bowl-shaped nanoparticles, allowing researchers to better understand the disease and potentially pr

Nanotechnology Now - Press Release: Nanoparticles help untangle Alzheimer s disease amyloid beta plaques: New research shows that the protein that causes Alzheimer s disease s hallmark brain plaques clings to certain bowl-shaped nanoparticles, allowing researchers to better understand the disease and potentially pr
nanotech-now.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nanotech-now.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoRatnesh lalVrinda santLeann foxUniversity of californiaMeeting of the biophysical societyBiophysical societyWave incHome press nanoparticlesMadhura somAnnual meetingNanotechnology nowஒன்றுபட்டது மாநிலங்களில்சான் டியாகோறத்னேஷ் லால்

Study shows why SARS-CoV-2 is more infectious than SARS-CoV-1

Coronavirus outbreaks have occurred periodically, but none have been as devastating as the COVID-19 pandemic.

United statesVivek govind kumarMahmoud moradiEmily hendersonPittsburgh supercomputing centerTexas advanced computing centerMeeting of the biophysical societyUniversity of arkansasGovind kumarAnnual meetingPittsburgh supercomputingCorona virusSpike proteinSars cov 2ஒன்றுபட்டது மாநிலங்களில்விவேக் கோவிந்த் குமார்

Researchers study how glycans activate SARS-CoV-2

Researchers study how glycans activate SARS-CoV-2 One thing that makes SARS-CoV-2, the virus that causes COVID-19, elusive to the immune system is that it is covered in sugars called glycans. Once SARS-CoV-2 infects someone s body, it becomes covered in that person s unique glycans, making it difficult for the immune system to recognize the virus as something it needs to fight. Those glycans also play an important role in activating the virus. Terra Sztain-Pedone, a graduate student, and colleagues in the labs of Rommie Amaro at the University of California, San Diego and Lillian Chong at the University of Pittsburgh, studied exactly how the glycans activate SARS-CoV-2. Sztain-Pedone will present the research on Thursday, February 25 at the 65th Annual Meeting of the Biophysical Society.

United statesSan diegoLillian chongRommie amaroJason mclellanEmily hendersonUniversity of californiaMeeting of the biophysical societyUniversity of pittsburghUniversity of texasAnnual meetingHigh performance computingSars cov 2Immune systemSpike proteinஒன்றுபட்டது மாநிலங்களில்

Nanobowls show potential for diagnostics and treatment of Alzheimer s

Scientists are still a long way from being able to treat Alzheimer's Disease, in part because the protein aggregates that can become brain plaques, a hallmark of the disease, are hard to study.

United statesSan diegoRatnesh lalVrinda santEmily hendersonUniversity of californiaMeeting of the biophysical societyMadhura somAnnual meetingGraduate studentAlzheimer 39s diseaseஒன்றுபட்டது மாநிலங்களில்சான் டியாகோறத்னேஷ் லால்விரிந்த சந்த்எமிலி ஹென்டர்சன்